Is NDZ a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

160 people get NDZ articles and Market Currents by email alert.

Get email alerts on NDZ »

HEADLINES:

Complete Chris Hansen And Valiant Capital Portfolio Update
Profit Fan • Fri, May 17
World Congress on Interventional Oncology to Present Live TheraSphere® Administration

Business Wire (Thu, 4:00PM)
Nordion Signs Contract Manufacturing Agreement with Navidea Biopharmaceuticals

Business Wire (May 15, 2013)
Profits Can Be Found In The Expanding And Challenging Medical Isotope Business
The Swiss Trader • Fri, May 3
Nordion to Host Interactive TheraSphere® Educational Session at the SIR Annual Scientific Meeting 2013

Business Wire (Apr 10, 2013)
Nordion to Host European-Based Educational and Scientific Meetings for Liver Cancer Specialists

Business Wire (Apr 9, 2013)
3 Radiotherapy Companies That Could Make Big Gains In 2013
Glen S. Woods • Mon, Apr 8 • 3 Comments
Medical Isotope Producers Could Be Lucrative Investment Ventures
Phil Lassiter • Wed, Apr 3
Nordion and Dr. Reddy’s Laboratories Settle Claims

Business Wire (Mar 21, 2013)
New Regulations To Phase Out HEU Radioisotopes May Phase In Money For Investors
The Swiss Trader • Mon, Mar 18 • 5 Comments
The Anti-Buffett Portfolio: Chris Hansen And Valiant Capital's Year-End Holdings
Profit Fan • Mon, Mar 11 • 2 Comments
Nordion Announces 2013 Annual Meeting Results

Business Wire (Mar 6, 2013)
Nordion's CEO Hosts 2013 Annual Shareholders Meeting (Transcript)
Wed, Mar 6
Nordion Management Discusses Q1 2013 Results - Earnings Call Transcript
Wed, Mar 6
Nordion Reports First Quarter Fiscal 2013 Financial Results

Business Wire (Mar 5, 2013)
Nordion Launches a New and Improved TheraSphere® Website to Meet the Needs of Liver Cancer Physicians, Patients and Caregivers Worldwide

Business Wire (Mar 5, 2013)
Nordion to Release First Quarter 2013 Financial Results

Business Wire (Feb 26, 2013)
Nordion Management Discusses Q4 2012 Results - Earnings Call Transcript
Mon, Jan 28
Nordion Appoints Mr. Grant Gardiner as SVP and General Counsel

Business Wire (Jan 28, 2013)
Nordion Reports Fourth Quarter and Fiscal 2012 Financial Results; Provides Fiscal 2013 Outlook

Business Wire (Jan 28, 2013)

To learn more about Seeking Alpha Pro, click here.

Nordion Continues To Prepare Investors For A New-Look Company
Teresa Dawn • Tue, Jan 22 • 10 Comments
Nordion's Future Does Not Look Bright
A John Hodge • Mon, Nov 12, 2012 • 2 Comments
Nordion's Strategic Makeover Makes It A Leader
Morningstar • Mon, Feb 27, 2012 • 1 Comment

Complete Chris Hansen And Valiant Capital Portfolio Update
Profit Fan • Fri, May 17
Profits Can Be Found In The Expanding And Challenging Medical Isotope Business
The Swiss Trader • Fri, May 3
3 Radiotherapy Companies That Could Make Big Gains In 2013
Glen S. Woods • Mon, Apr 8 • 3 Comments
Medical Isotope Producers Could Be Lucrative Investment Ventures
Phil Lassiter • Wed, Apr 3
New Regulations To Phase Out HEU Radioisotopes May Phase In Money For Investors
The Swiss Trader • Mon, Mar 18 • 5 Comments
The Anti-Buffett Portfolio: Chris Hansen And Valiant Capital's Year-End Holdings
Profit Fan • Mon, Mar 11 • 2 Comments
Targeted Radiation Looks To Create And Grow Revenue
The Swiss Trader • Wed, Dec 5, 2012 • 4 Comments
Top 10 Dogs In 8 Sectors Show Big Net Gains
Fredrik Arnold • Tue, Nov 27, 2012 • 9 Comments
3 Segments Within The Energy Sector To Monitor Over The Next 4 Years
Brian Nichols • Wed, Nov 21, 2012 • 24 Comments
A Change In Supply To Meet Isotope Demand
The Swiss Trader • Sun, Nov 4, 2012
White House Stance On Medical Isotopes May Leave Foreign Producers Nuked
The Swiss Trader • Wed, Aug 22, 2012
3 Biotech Companies Showing Promise In Radiotherapy Treatment
Cris Frangold • Fri, Aug 17, 2012
Healthcare Sector June Dogs See 9.99% Gains Projected For 2013
Fredrik Arnold • Wed, Jul 11, 2012 • 2 Comments
June Dog Recap Of 8 Sectors And The Dow: Gains Ahead
Fredrik Arnold • Wed, Jul 11, 2012 • 5 Comments
Radiation Treatments Look Poised To Grow In The Immediate Future
A John Hodge • Tue, Jun 19, 2012
Exploring The Innovation Of Cancer Treatments
The Swiss Trader • Fri, Jun 8, 2012 • 1 Comment
8 Sectors And Dow April Dividend Dog Report
Fredrik Arnold • Fri, Jun 1, 2012 • 4 Comments
Healthcare Dogs Stay Steady In April
Fredrik Arnold • Thu, May 24, 2012
5 Canadian Companies Rewarding Investors With Dividends And Buybacks
Bayesian Investing • Mon, Apr 9, 2012 • 1 Comment
16 Healthcare Stocks With Impressive Profitability
Kapitall • Tue, Mar 27, 2012 • 1 Comment

Nordion's CEO Hosts 2013 Annual Shareholders Meeting (Transcript)
Wed, Mar 6
Nordion Management Discusses Q1 2013 Results - Earnings Call Transcript
Wed, Mar 6
Nordion Management Discusses Q4 2012 Results - Earnings Call Transcript
Mon, Jan 28

World Congress on Interventional Oncology to Present Live TheraSphere® Administration

Business Wire (Thu, 4:00PM)
Nordion Signs Contract Manufacturing Agreement with Navidea Biopharmaceuticals

Business Wire (May 15, 2013)
Nordion to Host Interactive TheraSphere® Educational Session at the SIR Annual Scientific Meeting 2013

Business Wire (Apr 10, 2013)
Nordion to Host European-Based Educational and Scientific Meetings for Liver Cancer Specialists

Business Wire (Apr 9, 2013)
Nordion and Dr. Reddy’s Laboratories Settle Claims

Business Wire (Mar 21, 2013)
Nordion Announces 2013 Annual Meeting Results

Business Wire (Mar 6, 2013)
Nordion Reports First Quarter Fiscal 2013 Financial Results

Business Wire (Mar 5, 2013)
Nordion Launches a New and Improved TheraSphere® Website to Meet the Needs of Liver Cancer Physicians, Patients and Caregivers Worldwide

Business Wire (Mar 5, 2013)
Nordion to Release First Quarter 2013 Financial Results

Business Wire (Feb 26, 2013)
Nordion Appoints Mr. Grant Gardiner as SVP and General Counsel

Business Wire (Jan 28, 2013)
Nordion Reports Fourth Quarter and Fiscal 2012 Financial Results; Provides Fiscal 2013 Outlook

Business Wire (Jan 28, 2013)
Nordion, Manufacturer of TheraSphere®, to Host Educational Symposium at the 2013 Gastrointestinal Cancers Symposium

Business Wire (Jan 24, 2013)
Nordion to Release Fourth Quarter and Fiscal 2012 Financial Results

Business Wire (Jan 21, 2013)
Nordion Files Amended Statement of Claim in IPFA Proceedings

Business Wire (Jan 21, 2013)
Nordion Announces Postponement of Fourth Quarter 2012 Results and Earnings Conference Call

Business Wire (Dec 12, 2012)
Nordion Provides Update on MAPLE Arbitration Costs

Business Wire (Dec 4, 2012)
Nordion Restructures Russian Mo-99 Supply Relationship

Business Wire (Oct 29, 2012)
Nordion Provides Update on MAPLE Arbitration Costs Proceedings

Business Wire (Oct 22, 2012)
Nordion Extends Molybdenum-99 Supply Contract with Lantheus Medical Imaging, Inc. through 2015

Business Wire (Oct 22, 2012)
Indications: U.S. stock futures edge lower on data

at MarketWatch.com (Sep 20, 2012)

NDZ vs. ETF Alternatives

Company Description

Currently, there's no company description for NDZ.

Sector: Healthcare

Industry: Specialized Health Services

Country: Canada

All
| Earnings
| Dividends
| M&A
| On the move

Thursday, May 16, 10:16 AM Navidea Biopharmaceuticals (NAVB) says it's entered into an agreement with Nordion (NDZ -1%) to produce and supply its (123) labeled I-drug NAV5001 for late-phase clinical trials. NDZ will manufacture and supply of NAV5001 clinical trial material by radiolabeling NAVB's precursor drug product with Iodine-123 to form (123)I NAV5001, and then manage the logistics and shipping arrangements to third-party clinical trial sites. The agreement could be a precursor to a commercial supply arrangement in the future. Comment! [Healthcare, Global & FX]
Friday, March 22, 4:20 PM Dr. Reddy's Laboratories (RDY -1.1%) announces that it's settled claims against Nordion (NDZ +0.1%) by accepting a cash payment of $22.5M. The case was brought by RDY in April 2009 seeking damages caused by a purported breach by NDZ of its Laboratory Services Agreement with the company. 1 Comment [Global & FX, Healthcare]
Thursday, March 7, 2:21 PM Health science firm Nordion (NDZ +0.6%) ticks higher today on an upgrade at RBC Capital to Sector Perform on the back of its better than expected FQ1 earnings report yesterday, with a price target of $8 a share. The company also announced it had initiated a review of strategic alternatives with a view to enhancing shareholder value and creating new opportunities. Read more on earnings here: Earnings Call Transcript. 1 Comment [Healthcare, Earnings]
Tuesday, March 5, 5:03 PM Nordion (NDZ): FQ1 EPS of $0.07 beats by $0.04. Revenue of $53.7M (+1% Y/Y) beats by $3.7M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Monday, March 4, 5:39 PM After-hours top gainers, as of 5:15 p.m.: ASNA +13%. SNTS +8%. CPWR +4%. NDZ +3%. MTG +3%.
After-hours top losers: IPXL -20%. JCP -6%. GMXR -6%. TVL -3%. NSU -3%. Comment! [On the Move]
Monday, January 28, 7:03 AM Nordion (NDZ): Q4 EPS of $0.34 beats by $0.08. Revenue of $74.7M (+1% Y/Y) beats by $2M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Wednesday, December 12, 2012, 6:36 PM Nordion (NDZ) postpones the release of its Q4 and FY12 financial results and conference call scheduled for December 18 and 19, respectively, saying it's initiated discussions to amend the terms of the company’s credit facility. The discussions are related to the potential impact of ongoing litigation and the treatment of certain non-cash items. Shares -5.4% AH. Comment! [On the Move, Earnings]
Thursday, September 13, 2012, 10:47 AM Nordion (NDZ +1.8%) shakes up its management structure as the medical-technology company says it will realign its operations into two distinct business units with separate corporate structures: Targeted Therapies and Specialty Isotopes. The Company also appoints Jeff Brown, CEO and founding member of Brown Equity Partners, to its Board of Directors. Comment! [Healthcare, On the Move]
Monday, September 10, 2012, 12:44 PM Shares of Nordion (NDZ -35%) melt down after the company announced plans to suspend its quarterly dividend in response to an arbitration loss relating to claims against Atomic Energy of Canada for the cancelled construction of its MAPLE facilities. The facilities were the nuclear reactors and processing facility that were being constructed by AECL to serve as the source of NDZs long-term medical isotope supply. Comment! [Healthcare, Global & FX, On the Move]
Thursday, September 6, 2012, 12:43 PM Canadian medical-technology company Nordion (NDZ +0.8%) gains after its FQ3 swung to a profit on fewer one-time expenses and higher sales. The quarter marks a reversal as sales have slipped in recent quarters, due in part to supply interruptions and the temporary shutdown of a reactor. In its targeted-therapies segment, revenue grew 15%, while gross margins widened to 54.7% from 52.7%. Comment! [Healthcare, Earnings]
Wednesday, June 6, 2012, 12:44 PM Nordion (NDZ -7.2%) slides after its FQ2 missed Street expectations across the board. Revenue slipped across all of the medical-science company's main business segments, as special items weighed on Y/Y results. Comment! [Earnings, Healthcare, On the Move]
Thursday, January 19, 2012, 8:20 AM Nordion (NDZ) says it's entered a 6-year agreement to supply cobalt-60 to Synergy Health in locations across the world. The fast-growing market for Cobalt-60 products has grown to 40% of the sterilization of the world's single-use medical devices and supplies. Comment! [Healthcare]

NDZ Nordion Inc.

NDZ

Nordion Inc.